[LB-01] Late Breaking Symposium

[LB-01-06] Efficacy and safety of mirogabalin for CIPN: The prospective single-arm trial (MiroCIP study)

Sonoko Misawa
Tadamichi Denda
Sho Kodama
Takuji Suzuki
Yoichi Naito
Takahiro Kogawa
Mamoru Takada
Tomoki Suichi
Kazuhito Shiosakai
Satoshi Kuwabara
the MiroCIP study Group

(Department of Neurology, Graduate School of Medicine, Chiba University, Japan)
(Division of Gastroenterology, Chiba Cancer Center,Japan)
(Primary Medical Science Department, Medical Affairs Division, Daiichi Sankyo Co., Ltd., Japan)
(Department of Respirology, Graduate School of Medicine, Chiba University, Japan)
(Department of General Internal Medicine/Experimental Therapeutics/Medical Oncology, National Cancer Center Hospital East, Japan)
(Division of Early Clinical Development for Cancer, Advanced Medical Development Center, Cancer Institute Hospital of JFCR, Japan)
(Department of General Surgery, Graduate School of Medicine, Chiba University, Japan)
(Data Intelligence Department, Digital Transformation Management Division, Daiichi Sankyo Co., Ltd., Japan)
(the MiroCIP study Group, Japan)